D.A. DAVIDSON & CO. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 4 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,233,866
-28.2%
26,829
-10.2%
0.01%
-27.8%
Q2 2023$1,717,606
+1.6%
29,887
-33.7%
0.02%
-5.3%
Q1 2023$1,690,275
+23.3%
45,074
-7.8%
0.02%
+18.8%
Q4 2022$1,370,486
-0.6%
48,911
-0.4%
0.02%
-11.1%
Q3 2022$1,379,000
-21.2%
49,090
-2.5%
0.02%
-18.2%
Q2 2022$1,751,000
-4.6%
50,339
-1.6%
0.02%
+10.0%
Q1 2022$1,836,000
+3364.2%
51,134
+1604.5%
0.02%
+1900.0%
Q2 2017$53,000
+15.2%
3,000
-5.5%
0.00%0.0%
Q1 2017$46,000
-72.1%
3,175
-64.6%
0.00%
-75.0%
Q4 2016$165,000
-2.9%
8,9750.0%0.00%0.0%
Q3 2016$170,000
+18.1%
8,9750.0%0.00%0.0%
Q2 2016$144,000
+26.3%
8,975
-5.8%
0.00%0.0%
Q1 2016$114,000
-6.6%
9,525
+10.4%
0.00%0.0%
Q4 2015$122,000
+2340.0%
8,625
+1816.7%
0.00%
Q3 2015$5,000
-28.6%
4500.0%0.00%
Q2 2015$7,0004500.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders